P. Roy Vagelos, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 42,858 shares at $700.02 ($30.0M) on 2022-03-30, disclosed to the SEC on 2022-04-01.
Open-market sale of $30.0M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $700.00 | 14,286 | $10.0M | 33.3% |
| 2 | $700.02 | 14,286 | $10.0M | 33.3% |
| 3 | $700.02 | 14,286 | $10.0M | 33.3% |
| Total | $700.01 avg | 42,858 | $30.0M | 100% |
| Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |
| REGN | SELL | 2019-12-13 | $19.5M | — | Filing → |